Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasma fibrinogen concentration predicts risk myocardial infarction
… research represents an important step forward as the first study to use real-world effectiveness data in an economic …
HTA and Reimbursement Considerations for Orphan Drugs in European Markets HTA and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers? Heyes A, McBride D, Pearson I, Copley-Merriman C …
… Katica Boric Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Science, Neuroscience … is Research Epidemiologist in the Pharmacoepidemiology and Risk Management group with RTI-HS. Dr. Boric has extensive expertise in …
… collection that uses screened and verified physicians as study investigators for data collection and validation. “We’re pleased to have such a talented group of people joining our team. We look forward to ongoing … and managing partner. “MDA’s core capabilities in study design and collection of real-world outcomes data are a …
… is a Director in the Surveys and Observational Studies group at RTI-HS. She has more than 19 years of project … post authorization safety studies (PASS), risk evaluation and mitigation strategy (REMS) assessment … diseases. Ms. Sweeney's project experience includes study design and implementation protocol development, …
… Mary Anthony Pharmacoepidemiology and Risk Management Women's Health Rheumatology Diabetes & … at RTI-HS, she has focused on pharmacoepidemiology and risk management projects and works as an epidemiology … agency-required pregnancy safety studies, evaluation of risk management plans, approaches to benefit/risk assessment, …
… Statistical Association and Oncology Estimand Working Group of ASA BIOP & PSI/EFSPI. 10:25-10:55 am EST …
… For manufacturers who plan to set up outcomes-based or risk-sharing payment schemes, pre-approval/clearance … indications sought, such as information from clinical study protocols about endpoints being studied and the patient …
… Rothman here . Related Services Pharmacoepidemiology and Risk Management Staff Members Kenneth J Rothman …
… attributes that enable a more active lifestyle with lower risk of inhibitor development. Cano V, Mansfield C, Pierce A, … findings from a multinational medical record abstraction study. Cappellini MD, Yucel A, Meyers J, Jimenez M, Nham T, …